Clari Vest Asset Management LLC Intellia Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $64,153 - $89,581	2,770 Added 37.53%	10,151 $309,000
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $17,290 - $23,015	-500 Reduced 6.34%	7,381 $300,000
Q1 2023 May 08, 2023	BUY	$33.3 - $44.82 $732 - $986	22 Added 0.28%	7,881 $294,000
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $431 - $814	-13 Reduced 0.17%	7,859 $274,000
Q3 2022 Nov 10, 2022	SELL	$53.92 - $71.7 $1,186 - $1,577	-22 Reduced 0.28%	7,872 $441,000
Q1 2022 May 04, 2022	SELL	$58.27 - $118.99 $233 - $475	-4 Reduced 0.05%	7,894 $574,000
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $51,790 - $71,117	-514 Reduced 6.11%	7,898 $933,000
Q3 2021 Nov 08, 2021	BUY	$132.37 - $176.78 $624,521 - $834,048	4,718 Added 127.72%	8,412 $1.13 Million
Q2 2021 Aug 09, 2021	BUY	$60.88 - $161.91 $224,890 - $598,095	3,694 New	3,694 $598,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.